Free Trial
Gil Blum

Gil Blum Analyst Performance

Senior Biotech Analyst at Needham & Company LLC

Gil Blum is a stock analyst at Needham & Company LLC in the medical sector, covering 23 publicly traded companies. Over the past year, Gil Blum has issued 91 stock ratings, including buy, hold, and sell recommendations. While full access to Gil Blum's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Gil Blum's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
167 Last 4 Years
Buy Recommendations
91.46% 150 Buy Ratings
Companies Covered
23 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy91.5%150 ratings
Hold7.3%12 ratings
Sell1.2%2 ratings

Out of 164 total stock ratings issued by Gil Blum at Needham & Company LLC, the majority (91.5%) have been Buy recommendations, followed by 7.3% Hold and 1.2% Sell.

Exchange Coverage

ExchangePercentageCount
NASDAQ
100.0% of companies on NASDAQ
23 companies

Gil Blum, an analyst at Needham & Company LLC, currently covers 23 companies listed on , with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
23 companies
100.0%

Gil Blum of Needham & Company LLC specializes in stock coverage within the Medical sector.

Coverage Industries

IndustryPercentage
MED - BIOMED/GENE
20 companies
87.0%
MED - DRUGS
2 companies
8.7%
MED - GENERIC DRG
1 company
4.3%

About Gil Blum

Gil Blum, Ph.D., joined Needham & Company’s Biotech research team in August 2017. Gil joined Needham from Cadwalader Wickersham & Taft, New York oldest law firm where he was a Scientific Advisor in intellectual property law and prosecution. Prior to Cadwalader, Gil held a postdoctoral fellowship at the Memorial-Sloan Kettering Cancer Center, developing early drug candidates. Gil holds a Doctoral degree in Chemical Biology from Cornell University and a B.Sc. in Chemistry from Tel-Aviv University.
Follow on LinkedIn

Gil Blum's Ratings History at Needham & Company LLC

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Lyell Immunopharma, Inc. stock logo
LYEL
Lyell Immunopharma
6/3/2026Set Price Target$12.88$45.00
Cartesian Therapeutics, Inc. stock logo
RNAC
Cartesian Therapeutics
5/26/2026Lower Price Target$6.40$40.00Buy
Celcuity, Inc. stock logo
CELC
Celcuity
5/15/2026Reiterated Rating$134.72$157.00Buy
Nkarta, Inc. stock logo
NKTX
Nkarta
5/13/2026Reiterated Rating$3.28$11.00Buy
Artiva Biotherapeutics, Inc. stock logo
ARTV
Artiva Biotherapeutics
5/12/2026Boost Price Target$10.60$41.00Buy
Lyell Immunopharma, Inc. stock logo
LYEL
Lyell Immunopharma
5/7/2026Reiterated Rating$20.85$44.00Buy
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
5/7/2026Reiterated Rating$3.43$8.00Buy
Artiva Biotherapeutics, Inc. stock logo
ARTV
Artiva Biotherapeutics
5/4/2026Reiterated Rating$10.80$18.00Buy
Celcuity, Inc. stock logo
CELC
Celcuity
5/4/2026Boost Price Target$125.65$157.00Buy
Nurix Therapeutics, Inc. stock logo
NRIX
Nurix Therapeutics
4/23/2026Reiterated Rating$16.63$26.00Buy
Lyell Immunopharma, Inc. stock logo
LYEL
Lyell Immunopharma
4/10/2026Initiated Coverage$23.85$44.00Buy
Autolus Therapeutics PLC Sponsored ADR stock logo
AUTL
Autolus Therapeutics
4/9/2026Reiterated Rating$1.49$10.00Buy
Nurix Therapeutics, Inc. stock logo
NRIX
Nurix Therapeutics
4/8/2026Reiterated Rating$16.18$26.00Buy
Autolus Therapeutics PLC Sponsored ADR stock logo
AUTL
Autolus Therapeutics
3/27/2026Reiterated Rating$1.20$10.00Buy
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
3/26/2026Reiterated Rating$23.77Underperform
Nkarta, Inc. stock logo
NKTX
Nkarta
3/26/2026Boost Price Target$2.13$11.00Buy
Celcuity, Inc. stock logo
CELC
Celcuity
3/26/2026Reiterated Rating$110.22$122.00Buy
Absci Corporation stock logo
ABSI
Absci
3/25/2026Reiterated Rating$3.01$7.00Buy
Solid Biosciences Inc. stock logo
SLDB
Solid Biosciences
3/20/2026Reiterated Rating$7.12$19.00Buy
Taysha Gene Therapies, Inc. stock logo
TSHA
Taysha Gene Therapies
3/19/2026Boost Price Target$4.56$12.00Buy
Absci Corporation stock logo
ABSI
Absci
3/18/2026Reiterated Rating$3.03$7.00Buy
Celcuity, Inc. stock logo
CELC
Celcuity
3/17/2026Reiterated Rating$114.90$122.00Buy
Artiva Biotherapeutics, Inc. stock logo
ARTV
Artiva Biotherapeutics
3/11/2026Reiterated Rating$6.08$18.00Buy
Celcuity, Inc. stock logo
CELC
Celcuity
3/10/2026Boost Price Target$113.45$122.00Buy
Cartesian Therapeutics, Inc. stock logo
RNAC
Cartesian Therapeutics
3/9/2026Reiterated Rating$8.75$42.00Buy
Taysha Gene Therapies, Inc. stock logo
TSHA
Taysha Gene Therapies
3/3/2026Reiterated Rating$4.53$10.00Buy
Immunocore Holdings PLC Sponsored ADR stock logo
IMCR
Immunocore
2/26/2026Boost Price Target$32.16$75.00Buy
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
2/26/2026Reiterated Rating$3.77$8.00Buy
Arcellx, Inc. stock logo
ACLX
Arcellx
2/23/2026Downgrade$113.91Hold
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
2/13/2026Boost Price Target$48.93$82.00Buy
Solid Biosciences Inc. stock logo
SLDB
Solid Biosciences
2/9/2026Reiterated Rating$6.72$16.00Buy
Arcellx, Inc. stock logo
ACLX
Arcellx
2/5/2026Reiterated Rating$69.38$105.00Buy
Nurix Therapeutics, Inc. stock logo
NRIX
Nurix Therapeutics
1/29/2026Reiterated Rating$17.87$26.00Buy
Solid Biosciences Inc. stock logo
SLDB
Solid Biosciences
1/14/2026Reiterated Rating$5.79$16.00Buy
Mereo BioPharma Group plc - Sponsored ADR stock logo
MREO
Mereo BioPharma Group
1/13/2026Lower Price Target$0.57$3.00Buy
Autolus Therapeutics PLC Sponsored ADR stock logo
AUTL
Autolus Therapeutics
1/12/2026Lower Price Target$1.61$10.00Buy
Cartesian Therapeutics, Inc. stock logo
RNAC
Cartesian Therapeutics
1/9/2026Boost Price Target$7.92$42.00Buy
Autolus Therapeutics PLC Sponsored ADR stock logo
AUTL
Autolus Therapeutics
12/29/2025Boost Price Target$1.67$11.00Buy
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
12/23/2025Reiterated Rating$57.91$80.00Buy
Mereo BioPharma Group plc - Sponsored ADR stock logo
MREO
Mereo BioPharma Group
12/22/2025Reiterated Rating$2.00$5.00Buy
Stranded On The Flood Plains of History (Ad)

The petrodollar arrangement that Kissinger brokered in 1974 officially expired in June 2024. China has slashed U.S. Treasury holdings by 45% from peak, and central banks are swapping dollars for gold at the fastest pace since the Cold War. Porter Stansberry believes Trump is channeling more than $3 trillion toward securing the minerals, chips, and infrastructure that make AI possible - and companies at those chokepoints like Vertiv (up 500%), GE Vernova (up 700%), and Arista Networks (up 750%) are already moving. Porter's new briefing names one asset to buy today plus five stocks positioned at the narrowest chokepoints of what he calls the Silicon Dollar.tc pixel

Read Porter's full briefing and get the ticker names today
Amicus Therapeutics, Inc. stock logo
FOLD
Amicus Therapeutics
12/19/2025Downgrade$14.25Hold
Absci Corporation stock logo
ABSI
Absci
12/12/2025Reiterated Rating$3.84$7.00Buy
Autolus Therapeutics PLC Sponsored ADR stock logo
AUTL
Autolus Therapeutics
12/12/2025Reiterated Rating$1.59$10.00Buy
Nurix Therapeutics, Inc. stock logo
NRIX
Nurix Therapeutics
12/8/2025Reiterated Rating$18.09$26.00Buy
Arcellx, Inc. stock logo
ACLX
Arcellx
12/8/2025Reiterated Rating$69.56$105.00Buy
Solid Biosciences Inc. stock logo
SLDB
Solid Biosciences
12/4/2025Initiated Coverage$5.19$16.00Buy
Solid Biosciences Inc. stock logo
SLDB
Solid Biosciences
12/4/2025Initiated Coverage$5.77$16.00Buy
Absci Corporation stock logo
ABSI
Absci
11/13/2025Lower Price Target$3.40$7.00Buy
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
11/10/2025Lower Price Target$54.32$80.00Buy
Generation Bio Co. stock logo
GBIO
Generation Bio
11/7/2025Reiterated Rating$5.11$15.00Buy
Geron Corporation stock logo
GERN
Geron
11/5/2025Lower Price Target$1.10$4.00Buy
Nurix Therapeutics, Inc. stock logo
NRIX
Nurix Therapeutics
11/4/2025Reiterated Rating$12.62$26.00Buy
TScan Therapeutics, Inc. stock logo
TCRX
TScan Therapeutics
11/4/2025Lower Price Target$1.24$6.00Buy
Autolus Therapeutics PLC Sponsored ADR stock logo
AUTL
Autolus Therapeutics
11/3/2025Reiterated Rating$1.54$10.00Buy
Fate Therapeutics, Inc. stock logo
FATE
Fate Therapeutics
10/27/2025Reiterated Rating$1.65Hold
I-Mab Sponsored ADR stock logo
IMAB
I-Mab
10/24/2025Reiterated Rating$4.22$6.00Buy
Celcuity, Inc. stock logo
CELC
Celcuity
10/20/2025Set Price Target$72.21$95.00
Nurix Therapeutics, Inc. stock logo
NRIX
Nurix Therapeutics
10/20/2025Reiterated Rating$9.84$27.00Buy
Celcuity, Inc. stock logo
CELC
Celcuity
10/20/2025Reiterated Rating$51.96$70.00Buy
Autolus Therapeutics PLC Sponsored ADR stock logo
AUTL
Autolus Therapeutics
10/20/2025Reiterated Rating$1.62$10.00Buy
Taysha Gene Therapies, Inc. stock logo
TSHA
Taysha Gene Therapies
10/17/2025Reiterated Rating$5.08$10.00Buy
Artiva Biotherapeutics, Inc. stock logo
ARTV
Artiva Biotherapeutics
10/17/2025Reiterated Rating$2.77$18.00Buy
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
10/10/2025Reiterated Rating$72.92$81.00Buy
Celcuity, Inc. stock logo
CELC
Celcuity
10/3/2025Reiterated Rating$49.42$70.00Buy
Taysha Gene Therapies, Inc. stock logo
TSHA
Taysha Gene Therapies
10/2/2025Boost Price Target$4.45$10.00Buy
Amicus Therapeutics, Inc. stock logo
FOLD
Amicus Therapeutics
9/18/2025Upgrade$7.97$14.00Buy
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
9/11/2025Reiterated Rating$4.54$8.00Buy
I-Mab Sponsored ADR stock logo
IMAB
I-Mab
9/8/2025Reiterated Rating$4.28$6.00Buy
I-Mab Sponsored ADR stock logo
IMAB
I-Mab
8/20/2025Boost Price Target$4.52$6.00Buy
Celcuity, Inc. stock logo
CELC
Celcuity
8/15/2025Lower Price Target$51.89$70.00Buy
Nkarta, Inc. stock logo
NKTX
Nkarta
8/13/2025Reiterated Rating$1.96$10.00Buy
Absci Corporation stock logo
ABSI
Absci
8/13/2025Lower Price Target$2.97$8.00Buy
Generation Bio Co. stock logo
GBIO
Generation Bio
8/13/2025Reiterated Rating$6.41$15.00Buy
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
7/28/2025Reiterated Rating$11.93Underperform
Celcuity, Inc. stock logo
CELC
Celcuity
7/28/2025Reiterated Rating$13.77$29.00Buy
Rocket Pharmaceuticals, Inc. stock logo
RCKT
Rocket Pharmaceuticals
7/24/2025Reiterated Rating$3.36Hold
Autolus Therapeutics PLC Sponsored ADR stock logo
AUTL
Autolus Therapeutics
7/21/2025Reiterated Rating$2.57$10.00Buy
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
7/18/2025Downgrade$16.10Hold
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
7/17/2025Reiterated Rating$18.38$50.00Hold
Mereo BioPharma Group plc - Sponsored ADR stock logo
MREO
Mereo BioPharma Group
7/10/2025Set Price Target$2.94$5.00Buy
I-Mab Sponsored ADR stock logo
IMAB
I-Mab
7/9/2025Reiterated Rating$2.20$5.00Buy
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
7/8/2025Reiterated Rating$51.19$81.00Buy
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
7/8/2025Reiterated Rating$5.49$8.00Buy
Taysha Gene Therapies, Inc. stock logo
TSHA
Taysha Gene Therapies
7/1/2025Reiterated Rating$2.31$8.00Buy
Celcuity, Inc. stock logo
CELC
Celcuity
6/30/2025Reiterated Rating$12.90$29.00Buy
I-Mab Sponsored ADR stock logo
IMAB
I-Mab
6/27/2025Boost Price Target$2.02$5.00Buy
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
6/26/2025Reiterated Rating$46.56$81.00Buy
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
6/16/2025Lower Price Target$19.73$50.00Buy
Fate Therapeutics, Inc. stock logo
FATE
Fate Therapeutics
6/12/2025Reiterated Rating$1.55Hold
Autolus Therapeutics PLC Sponsored ADR stock logo
AUTL
Autolus Therapeutics
6/12/2025Reiterated Rating$2.16$10.00Buy
The roadshow starts Monday. This stock isn't ready. (Ad)

The SpaceX roadshow kicks off June 8. Goldman Sachs, the lead underwriter, will present the full S-1 to the world's largest fund managers - including a section naming one small company Musk's Colossus cannot operate without. Right now, most fund managers have never heard of it. By Friday, every one of them will. Dylan Jovine has identified the name and ticker before $75 billion in new capital starts chasing the SpaceX supply chain.tc pixel

Get the stock name and ticker before the roadshow begins
Taysha Gene Therapies, Inc. stock logo
TSHA
Taysha Gene Therapies
6/10/2025Reiterated Rating$2.80$8.00Buy
Taysha Gene Therapies, Inc. stock logo
TSHA
Taysha Gene Therapies
6/2/2025Reiterated Rating$2.78$8.00Buy
Rocket Pharmaceuticals, Inc. stock logo
RCKT
Rocket Pharmaceuticals
5/27/2025Downgrade$2.48$42.00Hold
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
5/20/2025Reiterated Rating$39.22$81.00Buy
Nkarta, Inc. stock logo
NKTX
Nkarta
5/15/2025Lower Price Target$1.87$10.00Buy
Celcuity, Inc. stock logo
CELC
Celcuity
5/15/2025Reiterated Rating$10.86$29.00Buy
Artiva Biotherapeutics, Inc. stock logo
ARTV
Artiva Biotherapeutics
5/15/2025Lower Price Target$1.81$18.00Buy
Fate Therapeutics, Inc. stock logo
FATE
Fate Therapeutics
5/14/2025Reiterated Rating$1.00Hold
Mereo BioPharma Group plc - Sponsored ADR stock logo
MREO
Mereo BioPharma Group
5/13/2025Reiterated Rating$2.45$7.00Buy
Generation Bio Co. stock logo
GBIO
Generation Bio
5/8/2025Reiterated Rating$3.90$80.00Buy
Cartesian Therapeutics, Inc. stock logo
RNAC
Cartesian Therapeutics
5/8/2025Lower Price Target$10.55$40.00Buy
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
5/7/2025Lower Price Target$46.75$125.00Buy
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
5/7/2025Lower Price Target$33.21$81.00Buy
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
5/6/2025Lower Price Target$4.76$8.00Buy
Nurix Therapeutics, Inc. stock logo
NRIX
Nurix Therapeutics
4/29/2025Reiterated Rating$11.62$27.00Buy
Celcuity, Inc. stock logo
CELC
Celcuity
4/11/2025Reiterated Rating$8.65$29.00Buy
Generation Bio Co. stock logo
GBIO
Generation Bio
4/10/2025Reiterated Rating$3.73$80.00Buy
Taysha Gene Therapies, Inc. stock logo
TSHA
Taysha Gene Therapies
4/10/2025Reiterated Rating$1.20$6.00Buy
Autolus Therapeutics PLC Sponsored ADR stock logo
AUTL
Autolus Therapeutics
4/10/2025Reiterated Rating$1.21$10.00Buy
Immunocore Holdings PLC Sponsored ADR stock logo
IMCR
Immunocore
4/10/2025Reiterated Rating$26.12$71.00Buy
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
4/9/2025Reiterated Rating$31.27$84.00Buy
Nkarta, Inc. stock logo
NKTX
Nkarta
4/9/2025Reiterated Rating$1.51$11.00Buy
Mereo BioPharma Group plc - Sponsored ADR stock logo
MREO
Mereo BioPharma Group
4/9/2025Reiterated Rating$1.76$7.00Buy
Cartesian Therapeutics, Inc. stock logo
RNAC
Cartesian Therapeutics
4/9/2025Reiterated Rating$9.52$41.00Buy
Rocket Pharmaceuticals, Inc. stock logo
RCKT
Rocket Pharmaceuticals
4/9/2025Reiterated Rating$4.79$42.00Buy
Nurix Therapeutics, Inc. stock logo
NRIX
Nurix Therapeutics
4/9/2025Lower Price Target$9.26$27.00Buy
TScan Therapeutics, Inc. stock logo
TCRX
TScan Therapeutics
4/8/2025Reiterated Rating$1.26$9.00Buy
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
4/8/2025Reiterated Rating$4.20$11.00Buy
Artiva Biotherapeutics, Inc. stock logo
ARTV
Artiva Biotherapeutics
4/8/2025Reiterated Rating$3.31$23.00Buy
I-Mab Sponsored ADR stock logo
IMAB
I-Mab
4/4/2025Reiterated Rating$0.73$4.00Buy
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
4/3/2025Lower Price Target$62.47$183.00Buy
Celcuity, Inc. stock logo
CELC
Celcuity
4/1/2025Reiterated Rating$10.11$29.00Buy
Autolus Therapeutics PLC Sponsored ADR stock logo
AUTL
Autolus Therapeutics
4/1/2025Lower Price Target$1.55$10.00Buy
Nkarta, Inc. stock logo
NKTX
Nkarta
3/27/2025Reiterated Rating$1.37$11.00Buy
Mereo BioPharma Group plc - Sponsored ADR stock logo
MREO
Mereo BioPharma Group
3/26/2025Reiterated Rating$2.27$7.00Buy
Artiva Biotherapeutics, Inc. stock logo
ARTV
Artiva Biotherapeutics
3/25/2025Reiterated Rating$3.91$23.00Buy
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
3/18/2025Reiterated Rating$79.44$202.00Buy
Generation Bio Co. stock logo
GBIO
Generation Bio
3/14/2025Reiterated Rating$5.12$80.00Buy
Cartesian Therapeutics, Inc. stock logo
RNAC
Cartesian Therapeutics
3/13/2025Reiterated Rating$16.46$41.00Buy
Geron Corporation stock logo
GERN
Geron
3/12/2025Reiterated Rating$1.60$5.00Buy
Immunocore Holdings PLC Sponsored ADR stock logo
IMCR
Immunocore
3/12/2025Reiterated Rating$28.42$71.00Buy
Fate Therapeutics, Inc. stock logo
FATE
Fate Therapeutics
3/6/2025Reiterated Rating$0.91Hold
TScan Therapeutics, Inc. stock logo
TCRX
TScan Therapeutics
3/5/2025Lower Price Target$1.92$9.00Buy
Rocket Pharmaceuticals, Inc. stock logo
RCKT
Rocket Pharmaceuticals
2/28/2025Lower Price Target$9.40$42.00Buy
Taysha Gene Therapies, Inc. stock logo
TSHA
Taysha Gene Therapies
2/27/2025Reiterated Rating$1.62$6.00Buy
Immunocore Holdings PLC Sponsored ADR stock logo
IMCR
Immunocore
2/27/2025Reiterated Rating$30.77$71.00Buy
Geron Corporation stock logo
GERN
Geron
2/27/2025Lower Price Target$1.61$5.00Buy
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
2/27/2025Reiterated Rating$106.86$202.00Buy
Amicus Therapeutics, Inc. stock logo
FOLD
Amicus Therapeutics
2/20/2025Reiterated Rating$9.56Hold
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
2/12/2025Reiterated Rating$39.62$84.00Buy
Stranded On The Flood Plains of History (Ad)

The petrodollar arrangement that Kissinger brokered in 1974 officially expired in June 2024. China has slashed U.S. Treasury holdings by 45% from peak, and central banks are swapping dollars for gold at the fastest pace since the Cold War. Porter Stansberry believes Trump is channeling more than $3 trillion toward securing the minerals, chips, and infrastructure that make AI possible - and companies at those chokepoints like Vertiv (up 500%), GE Vernova (up 700%), and Arista Networks (up 750%) are already moving. Porter's new briefing names one asset to buy today plus five stocks positioned at the narrowest chokepoints of what he calls the Silicon Dollar.tc pixel

Read Porter's full briefing and get the ticker names today
Celcuity, Inc. stock logo
CELC
Celcuity
2/6/2025Boost Price Target$12.74$29.00Buy
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
2/6/2025Reiterated Rating$7.46$11.00Buy
Nurix Therapeutics, Inc. stock logo
NRIX
Nurix Therapeutics
1/29/2025Lower Price Target$19.56$28.00Buy
Cartesian Therapeutics, Inc. stock logo
RNAC
Cartesian Therapeutics
1/27/2025Reiterated Rating$19.20$41.00Buy
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
1/27/2025Reiterated Rating$117.98$202.00Buy
Absci Corporation stock logo
ABSI
Absci
1/22/2025Initiated Coverage$3.22$9.00Buy
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
1/14/2025Reiterated Rating$118.43$202.00Buy
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
1/14/2025Reiterated Rating$38.85$84.00Buy
Amicus Therapeutics, Inc. stock logo
FOLD
Amicus Therapeutics
1/13/2025Reiterated Rating$9.02Hold
Mereo BioPharma Group plc - Sponsored ADR stock logo
MREO
Mereo BioPharma Group
1/13/2025Reiterated Rating$3.55$7.00Buy
Autolus Therapeutics PLC Sponsored ADR stock logo
AUTL
Autolus Therapeutics
1/13/2025Reiterated Rating$2.24$10.00Buy
Geron Corporation stock logo
GERN
Geron
1/13/2025Boost Price Target$2.89$7.00Buy
Cartesian Therapeutics, Inc. stock logo
RNAC
Cartesian Therapeutics
1/13/2025Reiterated Rating$17.45$41.00Buy
Immunocore Holdings PLC Sponsored ADR stock logo
IMCR
Immunocore
1/10/2025Reiterated Rating$29.93$71.00Buy